Welcome to LookChem.com Sign In|Join Free

CAS

  • or

273399-94-3

Post Buying Request

273399-94-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

273399-94-3 Usage

Description

(S)-FMOC-3-AMINO-2-(PHENYLSULFONYLAMINO)-PROPIONIC ACID is a chemical compound with the molecular formula C23H20N2O5S. It is a derivative of the amino acid proline, featuring a sulfonamide group and a fluorinated benzene ring. (S)-FMOC-3-AMINO-2-(PHENYLSULFONYLAMINO)-PROPIONIC ACID is characterized by its unique structure, which allows it to be a versatile building block in the synthesis of peptide molecules.

Uses

Used in Pharmaceutical Industry:
(S)-FMOC-3-AMINO-2-(PHENYLSULFONYLAMINO)-PROPIONIC ACID is used as a building block for the synthesis of peptide molecules, particularly in the development of new drugs. Its incorporation into peptide structures can potentially enhance the pharmacological properties of these drugs, making them more effective in treating various medical conditions.
Used in Research and Development:
In the field of peptide chemistry, (S)-FMOC-3-AMINO-2-(PHENYLSULFONYLAMINO)-PROPIONIC ACID is used as a key component in the design and synthesis of novel peptide-based compounds. Its unique structural features enable researchers to explore new avenues in drug discovery and the development of bioactive molecules with specific therapeutic applications.
Used in Solid-Phase Peptide Synthesis:
(S)-FMOC-3-AMINO-2-(PHENYLSULFONYLAMINO)-PROPIONIC ACID is used as a protected amino acid in solid-phase peptide synthesis. The FMOC protecting group shields the amino group from unwanted reactions, allowing for the stepwise assembly of peptide chains with greater precision and control. This technique is crucial for the efficient production of complex peptide molecules with specific sequences and functions.
Used in Structural Biology:
The sulfonamide group in (S)-FMOC-3-AMINO-2-(PHENYLSULFONYLAMINO)-PROPIONIC ACID can form hydrogen bonds, which may contribute to the structural and functional properties of the peptides it is incorporated into. This feature makes it a valuable tool in structural biology, where understanding the three-dimensional architecture of proteins and their interactions with other molecules is essential for elucidating biological processes and developing targeted therapeutic strategies.

Check Digit Verification of cas no

The CAS Registry Mumber 273399-94-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,3,3,9 and 9 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 273399-94:
(8*2)+(7*7)+(6*3)+(5*3)+(4*9)+(3*9)+(2*9)+(1*4)=183
183 % 10 = 3
So 273399-94-3 is a valid CAS Registry Number.

273399-94-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-2-(aminomethyl)-2-(benzenesulfonamido)-3-(9H-fluoren-9-ylmethoxy)-3-oxopropanoic acid

1.2 Other means of identification

Product number -
Other names N3-Fmoc-N2-benzenesulfonyl-L-2,3-diaminopropionic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:273399-94-3 SDS

273399-94-3Downstream Products

273399-94-3Relevant articles and documents

BENZIMIDAZOLE COMPOUNDS THAT ARE VITRONECTIN RECEPTOR ANTAGONISTS

-

Page/Page column 33-34, (2008/06/13)

The present invention provides compounds having formula (I) wherein n, p, q and r are each independently selected from 0 or 1; a, b, c, and d each independently represents a carbon or nitrogen atom, with the proviso that no more than two of a, b, c, and d are nitrogen atoms; Y and Y' each independently represents 1-4 optional substituents selected from alkyl, alkoxy, halo, -CF3, and -C(O)OH; R, R, R and R are H or specified substituents; R, R, R, R, R, R, R and R are independently selected from H or C1-C3 alkyl; or a biolabile ester thereof, or a pharmaceutically acceptable salt thereof. Also provided are methods of using these compounds for treating vitronectin-mediated disorders, e.g., cancer, retinopathy, artherosclerosis, vascular restenosis, and osteoporosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 273399-94-3